β‐Cell replacement as a treatment for type 1 diabetes: an overview of possible cell sources and current axes of research

Publisher： John Wiley & Sons Inc

E-ISSN： 1463-1326|18|S1|137-143

ISSN： 1462-8902

Source： DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.18, Iss.S1, 2016-09, pp. : 137-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pancreatic β‐cell identity in diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. S1, 2016-09 ,pp. : 110-116

John Wiley & Sons Inc

Access to resources Recommend Favorite

β‐Cell dysfunction in diabetes: a crisis of identity?

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. S1, 2016-09 ,pp. : 102-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adults with long‐duration type 2 diabetes have blunted glycemic and β‐Cell function improvements after bariatric surgery

By  

OBESITY, Vol. 23, Iss. 3, 2015-03 ,pp. : 523-526

John Wiley & Sons Inc

Access to resources Recommend Favorite

Imeglimin increases glucose‐dependent insulin secretion and improves β‐cell function in patients with type 2 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 541-545

John Wiley & Sons Inc

Access to resources Recommend Favorite

Coefficient of failure: a methodology for examining longitudinal β‐cell function in Type 2 diabetes

By  

DIABETIC MEDICINE, Vol. 19, Iss. 6, 2002-06 ,pp. : 465-469

John Wiley & Sons Inc

Access to resources Recommend Favorite